Bcl11a is a well-known proto-oncogene with BCL11A overexpression found to be associated with enhanced invasion and metastasis across multiple cancer types such as breast cancers, hematological malignancies, glioblastoma, or laryngeal squamous cell carcinoma [26,51,52,53]. Here, BCL11A is linked to hematologic disorder.